Amplexicaule A exerts anti-tumor effects by inducing apoptosis in human breast cancer

Oncotarget. 2016 Apr 5;7(14):18521-30. doi: 10.18632/oncotarget.7848.

Abstract

Chemotherapy is the main treatment for patients with breast cancer metastases, but natural alternatives have been receiving attention for their potential as novel anti-tumor reagents. Amplexicaule A (APA) is a flavonoid glucoside isolated from rhizomes of Polygonum amplexicaule D. Don var. sinense Forb (PADF). We found that APA has anti-tumor effects in a breast cancer xenograft mouse model and induces apoptosis in breast cancer cell lines. APA increased levels of cleaved caspase-3,-8,-9 and PARP, which resulted from suppression of MCL-1 and BCL-2 expression in the cells. APA also inactivated the Akt/mTOR pathway in breast cancer cells. Thus, APA exerts a strong anti-tumor effect on breast cancer cells, most likely through induction of apoptosis. Our study is the first to identify this novel anti-tumor compound and provides a new strategy for isolation and separation of single compounds from herbs.

Keywords: Akt/mTOR; MCL-1; amplexicaule A; apoptosis; breast cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Disease Models, Animal
  • Female
  • Flavonoids / pharmacology
  • Glucosides / pharmacology
  • Humans
  • MCF-7 Cells
  • Mice
  • Plant Extracts / pharmacology*
  • Polygonum / chemistry
  • Random Allocation
  • Xenograft Model Antitumor Assays

Substances

  • Flavonoids
  • Glucosides
  • Plant Extracts